Next earnings date: 15 Oct 2025

Intuitive Surgical, Inc. – LSE:0R29.L
Intuitive Surgical stock price today
Intuitive Surgical stock price monthly change
Intuitive Surgical stock price quarterly change
Intuitive Surgical stock price yearly change
Intuitive Surgical key metrics
Market Cap | 186.34B |
Enterprise value | N/A |
P/E | N/A |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | N/A |
PEG ratio | N/A |
EPS | 5.64 |
Revenue | 7.31B |
EBITDA | 2.18B |
Income | 1.98B |
Revenue Q/Q | 11.46% |
Revenue Y/Y | 13.80% |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | 29.92% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeIntuitive Surgical stock price history
Intuitive Surgical stock forecast
Intuitive Surgical financial statements
Jun 2023 | 1.75B | 420.8M | 23.96% |
---|---|---|---|
Sep 2023 | 1.74B | 415.7M | 23.84% |
Dec 2023 | 1.92B | 606.2M | 31.44% |
Mar 2024 | 1.89B | 544.9M | 28.82% |
Sep 2025 | 2.29B | 669.46M | 29.11% |
---|---|---|---|
Oct 2025 | 2.30B | 671.39M | 29.15% |
Dec 2025 | 2.50B | 712.05M | 28.46% |
Mar 2026 | 2.45B | 692.14M | 28.14% |
Analysts Price target
Financials & Ratios estimates
2024-10-17 | 1.64 | 1.56 |
---|
Jun 2023 | 13903300000 | 1.94B | 13.98% |
---|---|---|---|
Sep 2023 | 14712700000 | 2.08B | 14.2% |
Dec 2023 | 15441500000 | 2.04B | 13.24% |
Mar 2024 | 15828000000 | 1.78B | 11.26% |
Jun 2023 | 665.7M | 557.6M | 63.3M |
---|---|---|---|
Sep 2023 | 548.4M | -446.6M | 61.8M |
Dec 2023 | 228.3M | -1.04B | -31.5M |
Mar 2024 | 38.8M | -128.5M | 179.9M |
Intuitive Surgical alternative data
Aug 2023 | 12,120 |
---|---|
Sep 2023 | 12,120 |
Oct 2023 | 12,120 |
Nov 2023 | 12,120 |
Dec 2023 | 12,120 |
Jan 2024 | 12,120 |
Feb 2024 | 13,676 |
Mar 2024 | 13,676 |
Apr 2024 | 13,676 |
May 2024 | 13,676 |
Jun 2024 | 13,676 |
Jul 2024 | 13,676 |
Intuitive Surgical other data
Insider | Compensation |
---|---|
Dr. Gary S. Guthart (1966) Pres, Chief Executive Officer & Director | $1,600,000 |
Mr. David J. Rosa (1968) Executive Vice President & Chief Bus. Officer | $1,000,000 |
Mr. Salvatore J. Brogna (1955) Consultant & Advisor | $992,700 |
Mr. Marshall L. Mohr (1956) Executive Vice President & Chief Financial Officer | $935,100 |
Dr. Myriam J. Curet McAdams F.A.C.S., M.D. (1957) Executive Vice President & Chief Medical Officer | $827,720 |
Mr. Craig Child Senior Vice President of HR | |
Mr. Julian Nikolchev Senior Vice President of Corporation Devel. & Strategy | |
Ms. Kara Andersen Reiter Senior Vice President, Gen. Counsel & Chief Compliance Officer | |
Calvin Darling Senior Director of IR | |
Mr. Jamie E. Samath Senior Vice President of Fin. & Principal Accounting Officer |
-
What's the price of Intuitive Surgical stock today?
One share of Intuitive Surgical stock can currently be purchased for approximately $358.08.
-
When is Intuitive Surgical's next earnings date?
Intuitive Surgical, Inc. is estimated to report earnings on Wednesday, 15 Oct 2025.
-
Does Intuitive Surgical pay dividends?
No, Intuitive Surgical does not pay dividends.
-
How much money does Intuitive Surgical make?
Intuitive Surgical has a market capitalization of 186.34B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 14.49% to 7.12B US dollars. Intuitive Surgical earned 1.8B US dollars in net income (profit) last year or $1.56 on an earnings per share basis.
-
What is Intuitive Surgical's stock symbol?
Intuitive Surgical, Inc. is traded on the LSE under the ticker symbol "0R29.L".
-
What is Intuitive Surgical's primary industry?
Company operates in the Healthcare sector and Medical - Equipment & Services industry.
-
How do i buy shares of Intuitive Surgical?
Shares of Intuitive Surgical can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Intuitive Surgical's key executives?
Intuitive Surgical's management team includes the following people:
- Dr. Gary S. Guthart Pres, Chief Executive Officer & Director(age: 59, pay: $1,600,000)
- Mr. David J. Rosa Executive Vice President & Chief Bus. Officer(age: 57, pay: $1,000,000)
- Mr. Salvatore J. Brogna Consultant & Advisor(age: 70, pay: $992,700)
- Mr. Marshall L. Mohr Executive Vice President & Chief Financial Officer(age: 69, pay: $935,100)
- Dr. Myriam J. Curet McAdams F.A.C.S., M.D. Executive Vice President & Chief Medical Officer(age: 68, pay: $827,720)
- Mr. Craig Child Senior Vice President of HR
- Mr. Julian Nikolchev Senior Vice President of Corporation Devel. & Strategy
- Ms. Kara Andersen Reiter Senior Vice President, Gen. Counsel & Chief Compliance Officer
- Calvin Darling Senior Director of IR
- Mr. Jamie E. Samath Senior Vice President of Fin. & Principal Accounting Officer
-
How many employees does Intuitive Surgical have?
As Jul 2024, Intuitive Surgical employs 13,676 workers.
-
When Intuitive Surgical went public?
Intuitive Surgical, Inc. is publicly traded company for more then 10 years since IPO on 7 Nov 2014.
-
What is Intuitive Surgical's official website?
The official website for Intuitive Surgical is intuitive.com.
-
Where are Intuitive Surgical's headquarters?
Intuitive Surgical is headquartered at 1020 Kifer Road, Sunnyvale, CA.
-
How can i contact Intuitive Surgical?
Intuitive Surgical's mailing address is 1020 Kifer Road, Sunnyvale, CA and company can be reached via phone at +40 85232100.
Intuitive Surgical company profile:

Intuitive Surgical, Inc.
intuitive.comLSE
13,676
Medical - Equipment & Services
Healthcare
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing unified and connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
Sunnyvale, CA 94086-5304
:
ISIN: US46120E6023
: